Follicle Development

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated August 8, 2026

Follicle development is the process by which a cohort of ovarian follicles is recruited each cycle, one dominant follicle is selected and matures to ovulatory size, and the remaining follicles regress through atresia. FSH rises briefly at the transition from the luteal to the follicular phase, as the regressing corpus luteum stops producing progesterone, estradiol, and inhibin A, and that early rise recruits a cohort of antral follicles.¹ As the recruited cohort grows, rising estradiol and inhibin B from the follicles themselves feed back on the pituitary, and FSH falls across the remainder of the follicular phase. By cycle days 5 to 7, one follicle survives that decline and achieves dominance through greater FSH sensitivity and local estrogen production, while the rest lose FSH support and regress through atresia. That dominant follicle expands to approximately 18 to 24 mm, produces rising estradiol, and triggers the midcycle LH surge. The LH surge initiates the cascade that ends in follicle rupture, oocyte release, and corpus luteum formation.

The quality of the ovulatory event depends on the quality of follicle development. A follicle that does not reach adequate size before rupture produces a less mature oocyte and a smaller corpus luteum. A smaller corpus luteum means lower progesterone output across the luteal phase. Luteal phase deficiency does not always trace back to a deficient follicular phase: it can also follow a completely normal follicular and periovulatory phase, invisible on a basal body temperature chart that looks ovulatory.²

Serial transvaginal ultrasound across the periovulatory window, called a follicle maturation study, makes follicle development visible. It documents growth rate, dominant follicle size at the LH surge, and whether the follicle actually ruptures. That last point matters: a follicle can luteinize without releasing the oocyte, a condition called LUF syndrome, which standard hormone tests cannot detect. The sonographic ovulation classification system distinguishes LUF from a range of other ovulatory disorder patterns, each defined by exactly how the follicle deviates from normal collapse and oocyte release.

Normal follicle development is also a downstream marker of antral follicle count adequacy, thyroid function, and nutritional status. When follicle development is disordered, identifying the underlying cause matters before any intervention is designed. The Peak Day correlates with the moment of follicle rupture and oocyte release, anchoring cycle-timed diagnostics to the ovulatory event itself.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.